The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi

Obolski U, Swarthout TD, Kalizang’oma A, Mwalukomo TS, Chan JM, Weight CM, Brown C, Cave R, Cornick J, Kamng’ona AW, Msefula J, Ercoli G
,
et al
No abstract available
Keywords:

31 Biological Sciences

,

32 Biomedical and Clinical Sciences

,

3107 Microbiology

,

3202 Clinical Sciences

,

3207 Medical Microbiology

,

Prevention

,

Biotechnology

,

Immunization

,

Pneumonia

,

Genetics

,

Pediatric

,

Antimicrobial Resistance

,

Lung

,

Biodefense

,

Pneumonia & Influenza

,

Emerging Infectious Diseases

,

Infectious Diseases

,

Vaccine Related

,

3.4 Vaccines

,

Infection

,

Child

,

Humans

,

Animals

,

Mice

,

Infant

,

Child, Preschool

,

Streptococcus pneumoniae

,

Pneumococcal Infections

,

Anti-Bacterial Agents

,

Malawi

,

Virulence

,

Drug Resistance, Bacterial

,

Pneumococcal Vaccines

,

Serogroup

,

Nasopharynx

,

Carrier State